Skip to main content
Log in

Selective cannabinoid receptor agonist HU-210 decreases pump function of isolated perfused heart: Role of cAMP and cGMP

  • Biophysics and Biochemistry
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Abstract

The rate and strength of heart contractions decreased after 10-min perfusion of rat myocardium with Krebs—Henseleit solution containing a selective cannabinoid receptor agonist HU-210 in a final concentration of 10 nM. HU-210 completely blocked the positive inotropic and chronotropic effect of β-adrenoceptor agonist isoproterenol, decreased the basal level of cAMP, and abolished the isoproterenol-induced increase in myocardial cAMP concentration. cGMP concentration remained unchanged under these conditions. The decrease in myocardial cAMP concentration after activation of cannabinoid receptors did not correlate with changes in the strength and rate of heart contractions. Our results suggest that the negative inotropic and chronotropic effects of HU-210 are not associated with decreased cAMP concentration in the myocardium.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. I. Cavero, M. F. Lokhandwala, J. P. Buckley, and B. S. Jandhyla, Eur. J. Pharmacol., 29, No.1, 74–82 (1974).

    Google Scholar 

  2. C. C. Felder, J. S. Veluz, H. L. Williams, et al., Mol. Pharmacol., 42, 838–845 (1992).

    Google Scholar 

  3. A. C. Howlett, T. M. Champion, G. H. Wilker, and R. Mechoulam, Neuropharmacology, 29, No.2, 161–165 (1990).

    Google Scholar 

  4. B. R. Martin, S. P. Welch, and M. Abood, Advances in Pharmacology, New York (1995), pp. 342–397.

  5. L. N. Maslov and Yu. B. Lishmanov, Clin. Exp. Pharmacol. Physiol., 22, 812–816 (1995).

    Google Scholar 

  6. R. Mechoulam, J. J. Feigenbaum, N. Lander, et al., Experientia, 44, 762–764 (1984).

    Google Scholar 

  7. S. Mukhopadhyay, J.-Y. Shim, A. A. Assi, et al., Chem. Physics Lipids, 121, 91–109 (2002).

    Google Scholar 

  8. R. G. Pertwee, Curr. Med. Chem., No. 6, 635–664 (1999).

  9. D. Shire, C. Carrillon, M. Kaghad, et al., J. Biol. Chem., 270, No.8, 3726–3731 (1995).

    Google Scholar 

  10. K. A. Smiley, R. Karler, and S. A. Turkanis, Res. Commun. Chem. Pathol. Pharmacol., 14, 659–675 (1976).

    Google Scholar 

  11. H. Vidrio, M. A. Sanchez-Salvatori, and M. Medina, J. Cardiovasc. Pharmacol., 28, 332–336 (1996).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to L. N. Maslov.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 138, No. 12, pp. 622–625, December, 2004

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maslov, L.N., Lasukova, O.V., Krylatov, A.V. et al. Selective cannabinoid receptor agonist HU-210 decreases pump function of isolated perfused heart: Role of cAMP and cGMP. Bull Exp Biol Med 138, 550–553 (2004). https://doi.org/10.1007/s10517-005-0123-7

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-005-0123-7

Key Words

Navigation